Drugs / Sunscreen
Trials 0
Also used as a comparator or background therapy in 2 trials
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 0 | NCT07286318 Background | May 2026 → May 2027 expected | actinic keratosis, disease related to solid organ transplantation, skin squamous cell carcinoma | Marissa Lobl | Recruiting | No outcome recorded |
| Phase 0 | NCT03392623 Comparator | Jan 2015 → Jan 2016 | hyperpigmentation of the skin | Autonomous University of San Luis Potosí | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Sunscreen | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07286318 ↗ |
| Route | Topical | “Sunscreen application daily, broad spectrum SPF 30, to any sun exposed areas” NCT07286318 ↗ |